A F Verheul - JoVE Visualize

Showing results (31-40 of 43) with videos related to

Pageof 5

Sort By:

Clinical and Diagnostic Laboratory Immunology|March 10, 2001

Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccineW T Jansen, M Väkeväinen-Anttila, H Käyhty, et al.

Infection and Immunity|January 1, 1997

Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cellsW Chaka, A F Verheul, V V Vaishnav, et al.

FEMS Immunology and Medical Microbiology|November 27, 1999

Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structureA M Walenkamp, W S Chaka, A F Verheul, et al.

Clinical and Diagnostic Laboratory Immunology|November 1, 1994

Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodiesA F Verheul, A J Kuipers, A K Braat, et al.

Infection and Immunity|February 13, 2001

Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in miceW T Jansen, S Hogenboom, M J Thijssen, et al.

Vaccine|November 1, 1993

Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharideE Alonso de Velasco, A F Verheul, G H Veeneman, et al.

Vaccine|November 1, 1994

Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccinesE A DeVelasco, H A Dekker, P Antal, et al.

Infection and Immunity|June 25, 1998

Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptidesD P da Fonseca, D Joosten, R van der Zee, et al.

Journal of Immunological Methods|January 21, 1988

Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniquesG J Zigterman, A F Verheul, E B Ernste, et al.

Clinical and Experimental Immunology|February 1, 1997

Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replicationJ M Orendi, A F Verheul, N M De Vos, et al.

Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:

Pageof 5

Clinical and Diagnostic Laboratory Immunology|March 10, 2001

Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccineW T Jansen, M Väkeväinen-Anttila, H Käyhty, et al.

Infection and Immunity|January 1, 1997

Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cellsW Chaka, A F Verheul, V V Vaishnav, et al.

FEMS Immunology and Medical Microbiology|November 27, 1999

Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structureA M Walenkamp, W S Chaka, A F Verheul, et al.

Clinical and Diagnostic Laboratory Immunology|November 1, 1994

Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodiesA F Verheul, A J Kuipers, A K Braat, et al.

Infection and Immunity|February 13, 2001

Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in miceW T Jansen, S Hogenboom, M J Thijssen, et al.

Vaccine|November 1, 1993

Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharideE Alonso de Velasco, A F Verheul, G H Veeneman, et al.

Vaccine|November 1, 1994

Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccinesE A DeVelasco, H A Dekker, P Antal, et al.

Infection and Immunity|June 25, 1998

Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptidesD P da Fonseca, D Joosten, R van der Zee, et al.

Journal of Immunological Methods|January 21, 1988

Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniquesG J Zigterman, A F Verheul, E B Ernste, et al.

Clinical and Experimental Immunology|February 1, 1997

Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replicationJ M Orendi, A F Verheul, N M De Vos, et al.

Pageof 5